Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy | MicrobiomeTrials← Back to trialsNCT07815301
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-12Est. Completion: 2028-12
Enrollment target: 286 participants Locations- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Other microbiome trials you might be interested in
Cardiomyopathy, Hypertrophic Obstructive
The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of o…
Multiple LocationsEst. completion Oct 2028
Obstructive Hypertrophic Cardiomyopathy (oHCM)
This study aims to evaluate whether, under a treatment strategy primarily guided by left ventricular ejection fraction (…
Multiple LocationsEst. completion Sep 2026